vs
Side-by-side financial comparison of RHYTHM PHARMACEUTICALS, INC. (RYTM) and FIRST FINANCIAL CORP (THFF). Click either name above to swap in a different company.
FIRST FINANCIAL CORP is the larger business by last-quarter revenue ($70.5M vs $57.3M, roughly 1.2× RHYTHM PHARMACEUTICALS, INC.). FIRST FINANCIAL CORP runs the higher net margin — 30.4% vs -83.0%, a 113.4% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 14.1%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 20.8%).
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
First American Financial Corporation is an American financial services company which provides title insurance and settlement services to the real estate and mortgage industries.
RYTM vs THFF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $57.3M | $70.5M |
| Net Profit | $-47.5M | $21.5M |
| Gross Margin | 91.6% | — |
| Operating Margin | -82.2% | 37.4% |
| Net Margin | -83.0% | 30.4% |
| Revenue YoY | 36.9% | 14.1% |
| Net Profit YoY | -9.6% | 32.1% |
| EPS (diluted) | $-0.73 | $1.81 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $57.3M | $70.5M | ||
| Q3 25 | $51.3M | $65.8M | ||
| Q2 25 | $48.5M | $63.1M | ||
| Q1 25 | $32.7M | $62.5M | ||
| Q4 24 | $41.8M | $61.8M | ||
| Q3 24 | $33.3M | $58.4M | ||
| Q2 24 | $29.1M | $49.2M | ||
| Q1 24 | $26.0M | $48.4M |
| Q4 25 | $-47.5M | $21.5M | ||
| Q3 25 | $-52.9M | $20.8M | ||
| Q2 25 | $-46.6M | $18.6M | ||
| Q1 25 | $-49.5M | $18.4M | ||
| Q4 24 | $-43.3M | $16.2M | ||
| Q3 24 | $-43.6M | $8.7M | ||
| Q2 24 | $-32.3M | $11.4M | ||
| Q1 24 | $-141.4M | $10.9M |
| Q4 25 | 91.6% | — | ||
| Q3 25 | 89.3% | — | ||
| Q2 25 | 88.6% | — | ||
| Q1 25 | 88.8% | — | ||
| Q4 24 | 90.9% | — | ||
| Q3 24 | 88.5% | — | ||
| Q2 24 | 89.9% | — | ||
| Q1 24 | 89.2% | — |
| Q4 25 | -82.2% | 37.4% | ||
| Q3 25 | -102.6% | 39.2% | ||
| Q2 25 | -93.4% | 36.2% | ||
| Q1 25 | -143.7% | 38.1% | ||
| Q4 24 | -98.6% | 32.4% | ||
| Q3 24 | -132.0% | 17.9% | ||
| Q2 24 | -139.2% | 27.6% | ||
| Q1 24 | -538.7% | 27.2% |
| Q4 25 | -83.0% | 30.4% | ||
| Q3 25 | -103.1% | 31.6% | ||
| Q2 25 | -96.1% | 29.5% | ||
| Q1 25 | -151.4% | 29.5% | ||
| Q4 24 | -103.6% | 26.3% | ||
| Q3 24 | -131.2% | 15.0% | ||
| Q2 24 | -110.9% | 23.1% | ||
| Q1 24 | -544.4% | 22.6% |
| Q4 25 | $-0.73 | $1.81 | ||
| Q3 25 | $-0.82 | $1.75 | ||
| Q2 25 | $-0.75 | $1.57 | ||
| Q1 25 | $-0.81 | $1.55 | ||
| Q4 24 | $-0.71 | $1.37 | ||
| Q3 24 | $-0.73 | $0.74 | ||
| Q2 24 | $-0.55 | $0.96 | ||
| Q1 24 | $-2.35 | $0.93 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $388.9M | — |
| Total DebtLower is stronger | — | $188.2M |
| Stockholders' EquityBook value | $139.1M | $650.9M |
| Total Assets | $480.2M | $5.8B |
| Debt / EquityLower = less leverage | — | 0.29× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $388.9M | — | ||
| Q3 25 | $416.1M | — | ||
| Q2 25 | $291.0M | — | ||
| Q1 25 | $314.5M | — | ||
| Q4 24 | $320.6M | — | ||
| Q3 24 | $298.4M | — | ||
| Q2 24 | $319.1M | — | ||
| Q1 24 | $201.2M | — |
| Q4 25 | — | $188.2M | ||
| Q3 25 | — | $170.5M | ||
| Q2 25 | — | $122.7M | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | — | $28.1M | ||
| Q3 24 | — | $30.5M | ||
| Q2 24 | — | $108.6M | ||
| Q1 24 | — | $58.6M |
| Q4 25 | $139.1M | $650.9M | ||
| Q3 25 | $148.8M | $622.2M | ||
| Q2 25 | $-11.9M | $587.7M | ||
| Q1 25 | $18.9M | $571.9M | ||
| Q4 24 | $21.7M | $549.0M | ||
| Q3 24 | $11.2M | $566.0M | ||
| Q2 24 | $39.3M | $530.7M | ||
| Q1 24 | $61.6M | $520.8M |
| Q4 25 | $480.2M | $5.8B | ||
| Q3 25 | $506.9M | $5.7B | ||
| Q2 25 | $372.7M | $5.6B | ||
| Q1 25 | $386.7M | $5.5B | ||
| Q4 24 | $392.3M | $5.6B | ||
| Q3 24 | $363.6M | $5.5B | ||
| Q2 24 | $381.8M | $4.9B | ||
| Q1 24 | $258.7M | $4.9B |
| Q4 25 | — | 0.29× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.21× | ||
| Q1 25 | — | 0.22× | ||
| Q4 24 | — | 0.05× | ||
| Q3 24 | — | 0.05× | ||
| Q2 24 | — | 0.20× | ||
| Q1 24 | — | 0.11× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-25.4M | $90.4M |
| Free Cash FlowOCF − Capex | — | $86.4M |
| FCF MarginFCF / Revenue | — | 122.5% |
| Capex IntensityCapex / Revenue | — | 5.6% |
| Cash ConversionOCF / Net Profit | — | 4.21× |
| TTM Free Cash FlowTrailing 4 quarters | — | $144.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-25.4M | $90.4M | ||
| Q3 25 | $-26.6M | $26.9M | ||
| Q2 25 | $-23.3M | $12.7M | ||
| Q1 25 | $-40.4M | $21.1M | ||
| Q4 24 | $-18.8M | $60.4M | ||
| Q3 24 | $-25.2M | $23.3M | ||
| Q2 24 | $-29.1M | $8.8M | ||
| Q1 24 | $-40.7M | $12.4M |
| Q4 25 | — | $86.4M | ||
| Q3 25 | — | $25.8M | ||
| Q2 25 | — | $11.6M | ||
| Q1 25 | — | $20.5M | ||
| Q4 24 | — | $54.3M | ||
| Q3 24 | — | $19.5M | ||
| Q2 24 | — | $8.4M | ||
| Q1 24 | — | $11.5M |
| Q4 25 | — | 122.5% | ||
| Q3 25 | — | 39.2% | ||
| Q2 25 | — | 18.4% | ||
| Q1 25 | — | 32.8% | ||
| Q4 24 | — | 87.8% | ||
| Q3 24 | — | 33.5% | ||
| Q2 24 | — | 17.2% | ||
| Q1 24 | — | 23.7% |
| Q4 25 | — | 5.6% | ||
| Q3 25 | — | 1.7% | ||
| Q2 25 | — | 1.8% | ||
| Q1 25 | — | 0.9% | ||
| Q4 24 | — | 9.9% | ||
| Q3 24 | — | 6.5% | ||
| Q2 24 | — | 0.7% | ||
| Q1 24 | — | 2.0% |
| Q4 25 | — | 4.21× | ||
| Q3 25 | — | 1.29× | ||
| Q2 25 | — | 0.68× | ||
| Q1 25 | — | 1.14× | ||
| Q4 24 | — | 3.72× | ||
| Q3 24 | — | 2.67× | ||
| Q2 24 | — | 0.77× | ||
| Q1 24 | — | 1.14× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
